{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T18:48:30Z","timestamp":1785005310845,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20269"],"award-info":[{"award-number":["U22A20269"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1311300"],"award-info":[{"award-number":["2018YFC1311300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejphar.2023.175679","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T12:09:02Z","timestamp":1679659742000},"page":"175679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling"],"prefix":"10.1016","volume":"947","author":[{"given":"Zheng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Han","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2210-3169","authenticated-orcid":false,"given":"Qi-Zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175679_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cvr\/cvv186","article-title":"Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia","volume":"107","author":"andersson","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2023.175679_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","article-title":"Septic cardiomyopathy","volume":"46","author":"Beesley","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2023.175679_bib3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.immuni.2009.04.011","article-title":"Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2","volume":"30","author":"bertrand","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2023.175679_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212262","article-title":"Cytokine-mediated alterations of human cardiac fibroblast's secretome","volume":"22","author":"br\u00e4uninger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.175679_bib5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/416190a","article-title":"Involvement of receptor-interacting protein 2 in innate and adaptive immune responses","volume":"416","author":"Chin","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2023.175679_bib6","first-page":"700","article-title":"NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer","volume":"123","author":"couturier-maillard","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175679_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11897-014-0247-z","article-title":"Pathophysiology of sepsis-related cardiac dysfunction: driven by inflammation, energy mismanagement, or both?","volume":"12","author":"Drosatos","year":"2015","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.ejphar.2023.175679_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.01.016","article-title":"Disruption of XIAP-RIP2 association blocks NOD2-mediated inflammatory signaling","volume":"69","author":"Goncharov","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2023.175679_bib9","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1038\/s41467-018-07447-9","article-title":"Structural basis of RIP2 activation and signaling","volume":"9","author":"Gong","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.175679_bib10","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1096\/fj.201801231RR","article-title":"Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM\u20101","volume":"33","author":"gonz\u00e1lez-ramos","year":"2019","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2023.175679_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","article-title":"A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-kappaB activation","volume":"27","author":"hasegawa","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.ejphar.2023.175679_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108648","article-title":"Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity","volume":"223","author":"Hofmann","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2023.175679_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/intimm\/dxaa062","article-title":"ATG16L1 negatively regulates RICK\/RIP2-mediated innate immune responses","volume":"33","author":"Honjo","year":"2021","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejphar.2023.175679_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.650403","article-title":"RIPK2 as a new therapeutic target in inflammatory bowel diseases","volume":"12","author":"Honjo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175679_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2016.10.014","article-title":"Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1\/M2 balance in vitro","volume":"101","author":"humeres","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175679_bib16","doi-asserted-by":"crossref","first-page":"27823","DOI":"10.1074\/jbc.M003415200","article-title":"An induced proximity model for NF-kappa B activation in the Nod1\/RICK and RIP signaling pathways","volume":"275","author":"Inohara","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175679_bib17","doi-asserted-by":"crossref","first-page":"11964","DOI":"10.1074\/jbc.M707750200","article-title":"The role of RIP2 in p38 MAPK activation in the stressed heart","volume":"283","author":"Jacquet","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175679_bib18","doi-asserted-by":"crossref","first-page":"35874","DOI":"10.1074\/jbc.M111.242321","article-title":"Interaction patches of procaspase-1 caspase recruitment domains (CARDs) are differently involved in procaspase-1 activation and receptor-interacting protein 2 (RIP2)-dependent nuclear factor \u03baB signaling","volume":"286","author":"Kersse","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175679_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jacc.2006.02.069","article-title":"Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality","volume":"48","author":"Larche","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175679_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00395-015-0515-4","article-title":"Regulatory role of CARD3 in left ventricular remodelling and dysfunction after myocardial infarction","volume":"110","author":"Li","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175679_bib21","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1161\/CIRCULATIONAHA.119.041213","article-title":"Innate immune nod1\/RIP2 signaling is essential for cardiac hypertrophy but requires mitochondrial antiviral signaling protein for signal transductions and energy balance","volume":"142","author":"Lin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175679_bib22","article-title":"Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF \u03b2\/Smad activation and cardiac fibrosis induced by angiotensin II","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2023.175679_bib23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1378\/chest.129.5.1349","article-title":"Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides","volume":"129","author":"Maeder","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2023.175679_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.ejphar.2023.175679_bib25","doi-asserted-by":"crossref","first-page":"16968","DOI":"10.1074\/jbc.273.27.16968","article-title":"RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase","volume":"273","author":"Mccarthy","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175679_bib26","doi-asserted-by":"crossref","first-page":"33684","DOI":"10.1074\/jbc.274.47.33684","article-title":"RIP2 is a Raf1-activated mitogen-activated protein kinase kinase","volume":"274","author":"Navas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175679_bib27","doi-asserted-by":"crossref","first-page":"19183","DOI":"10.1074\/jbc.M109.006353","article-title":"The kinase activity of Rip2 determines its stability and consequently Nod1- and Nod2-mediated immune responses","volume":"284","author":"Nembrini","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175679_bib28","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.4049\/jimmunol.178.4.2380","article-title":"RICK\/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs","volume":"178","author":"Park","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.175679_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.01.090","article-title":"Non-canonical caspase-1 signaling drives RIP2-dependent and TNF-\u03b1-mediated inflammation in vivo","volume":"30","author":"Reinke","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2023.175679_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00134-010-2051-x","article-title":"Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome","volume":"37","author":"Rosjo","year":"2011","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejphar.2023.175679_bib31","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCHEARTFAILURE.110.959833","article-title":"Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor gamma coactivator-1 signaling","volume":"4","author":"Schilling","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejphar.2023.175679_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bbadis.2018.10.011","article-title":"The role of mitochondria in sepsis-induced cardiomyopathy","volume":"1865","author":"Stanzani","year":"2019","journal-title":"Biochim. Biophys. Acta, Mol. Basis Dis."},{"key":"10.1016\/j.ejphar.2023.175679_bib33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jss.2014.09.012","article-title":"Cardiac fibroblasts: contributory role in septic cardiac dysfunction","volume":"193","author":"Tomita","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejphar.2023.175679_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.yjmcc.2015.11.002","article-title":"Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)","volume":"94","author":"Turner","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175679_bib35","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.celrep.2017.05.084","article-title":"NOD2 suppresses colorectal tumorigenesis via downregulation of the TLR pathways","volume":"19","author":"Udden","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2023.175679_bib36","first-page":"545","article-title":"Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis","volume":"118","author":"Watanabe","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.175679_bib37","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/ni1092","article-title":"NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses","volume":"5","author":"Watanabe","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2023.175679_bib38","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/intimm\/dxz045","article-title":"RICK\/RIP2 is a NOD2-independent nodal point of gut inflammation","volume":"31","author":"Watanabe","year":"2019","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejphar.2023.175679_bib39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20061704","article-title":"Molecular mechanisms involved in the regulation of cytokine production by muramyl dipeptide","volume":"404","author":"Windheim","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2023.175679_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.688238","article-title":"Cardiomyocyte-specific RIP2 overexpression exacerbated pathologic remodeling and contributed to spontaneous cardiac hypertrophy","volume":"9","author":"Yang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2023.175679_bib41","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.yjmcc.2014.06.003","article-title":"High-mobility group box 1 (HMGB1) impaired cardiac excitation-contraction coupling by enhancing the sarcoplasmic reticulum (SR) Ca(2+) leak through TLR4-ROS signaling in cardiomyocytes","volume":"74","author":"Zhang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:15:54Z","timestamp":1757978154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":41,"alternative-id":["S0014299923001905"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175679","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175679"}}